№ files_lp_4_process_1_30676
File format: docx Character count: 1611 File size: 100 KB
A retrospective clinical study analyzing the relationship between glycemic control and cardiovascular outcomes in morbidly obese patients undergoing atrial fibrillation ablation
Year: 2026
Region / City: Not specified
Topic: Cardiology, Obesity, Atrial Fibrillation
Document Type: Research Study
Institution: Not specified
Author: Not specified
Target Audience: Cardiologists, medical researchers, healthcare professionals
Study Population: Morbidly obese patients with BMI ≥35 kg/m² undergoing AF catheter ablation
Sample Size: 217 patients
Methods: Retrospective observational study
Primary Outcome: Composite of recurrent atrial arrhythmias and cardiovascular hospitalizations
Risk Factors Analyzed: BMI fluctuations, blood pressure, obstructive sleep apnea, hyperlipidemia, tobacco use, alcohol use, diabetes mellitus with HbA1c >6.5%
Follow-up Period: Mean 2.9 years after ablation
Key Findings: Only HbA1c >6.5% independently predicted primary outcome; timing of ablation did not affect outcomes
Conclusion: Optimizing glycemic control is crucial for reducing recurrent atrial arrhythmias and cardiovascular hospitalizations in morbidly obese patients undergoing AF ablation
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Q&A Diagnostic Arrhythmia and Device Monitoring
Note: Year
Letter of Medical Necessity for the Arrhythmia Panel
Year: 2026
Region / City: Gaithersburg, MD
Topic: Medical Necessity, Genetic Testing
Document Type: Letter
Organization: GeneDx, Inc.
Target Audience: Insurance Companies, Medical Reviewers
Action Period: N/A
Approval Date: N/A
Amendment Date: N/A
Mortality and HF Hospitalizations in HFpEF Compared to HFrEF: A Systematic Review and Meta-Analysis
Year: 2024
Region / City: Global
Topic: Heart failure, epidemiology, meta-analysis
Document Type: Research article
Institution: University of Liverpool, Liverpool John Moores University, Medical University of Silesia
Author: Krzysztof Irlik, Julia Piaśnik, Mirela Hendel, Urszula Faron, Gregory Y. H. Lip, Katarzyna Nabrdalik, Konstantinos Prokopidis
Target Audience: Medical researchers, healthcare professionals, cardiologists
Period of validity: Ongoing research
Approval Date: 2024
Date of Changes: None
Keywords: Heart failure, HFpEF, HFrEF, Mortality, Hospitalization, Meta-analysis
PROSPERO registration ID: CRD42024619499
Description: A systematic review and meta-analysis comparing clinical outcomes between heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF), focusing on mortality rates and hospitalizations.
Hospitalizations for Alcoholic Liver Disease During the COVID-19 Pandemic Increased More for Women, Especially Young Women, Compared to Men
Year: 2023
Journal: World Journal of Hepatology
Volume: 15
Issue: 2
Pages: 282–288
DOI: 10.4254/wjh.v15.i2.282
Article type: Original article
Study design: Retrospective study
Topic: Alcoholic liver disease admissions during the COVID-19 pandemic
Medical field: Hepatology
Authors: John Patterson Campbell; Vinay Jahagirdar; Adel Muhanna; Kevin F. Kennedy; John H. Helzberg
Affiliated institutions: Saint Luke’s Health System of Kansas City; University of Missouri–Kansas City
Country: United States
Data source: Multi-hospital electronic health system database
Study population: Patients admitted with alcoholic liver disease identified using ICD-10 codes
Study period: April 2019 – March 2021
Comparison periods: Pre-COVID-19 (April 2019 – March 2020); During COVID-19 (April 2020 – March 2021)
Methodology: Poisson regression analysis with stratification by age and gender
Date received: November 4, 2022
Date revised: January 15, 2023
Date accepted: February 7, 2023
Online publication date: February 27, 2023
Publisher: Baishideng Publishing Group Inc.
Corresponding author: John Patterson Campbell
Corresponding author affiliation: Department of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Luke’s Health System of Kansas City and the University of Missouri–Kansas City
Keywords: Alcoholic liver disease; COVID-19; Alcoholic hepatitis; Alcoholic liver cirrhosis; Alcoholism; Pandemic; Young women; Alcohol-related disorders
Topics: Morbidly Arrhythmia Hospitalizations